Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-13

Clinical Trial Update: Nepafenac Compared to Placebo for Ocular Pain and Inflammation [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing nepafenac eye drops to placebo for reducing ocular pain and inflammation after cataract surgery. The trial results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nevanac (nepafenac)

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 3 | Status: COMPLETED | Results posted: 2013-05-13